Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults

The immunogenicity of the candidate tuberculosis (TB) vaccine MVA85A may be enhanced by aerosol delivery. Intradermal administration was shown to be safe in adults with latent TB infection (LTBI), but data are lacking for aerosol-delivered candidate TB vaccines in this population. We carried out a P...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Riste, M, Marshall, JL, Satti, I, Harris, SA, Wilkie, M, Lopez Ramon, R, Wright, D, Wittenberg, RE, Vermaak, S, Powell Doherty, R, Lawrie, A, Conlon, CP, Cosgrove, C, Gleeson, F, Lipman, M, Moss, P, Perrin, F, Dedicoat, M, Bettinson, H, McShane, H
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	MDPI 2021

Những quyển sách tương tự

Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy <em>M.tb</em>-Infected Adults
Bằng: Michael Riste, et al.
Được phát hành: (2021-04-01)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
Bằng: Thomas, Z, et al.
Được phát hành: (2014)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
Bằng: Tameris, M, et al.
Được phát hành: (2014)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
Bằng: Tameris, M, et al.
Được phát hành: (2014)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
Bằng: Mcshane, H
Được phát hành: (2008)

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial
Bằng: Manjaly Thomas, Z, et al.
Được phát hành: (2019)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
Bằng: Rowland, R, et al.
Được phát hành: (2012)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
Bằng: Michele Tameris, et al.
Được phát hành: (2014-01-01)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
Bằng: Harris, S, et al.
Được phát hành: (2011)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
Bằng: Meyer, J, et al.
Được phát hành: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
Bằng: Meyer, J, et al.
Được phát hành: (2013)

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
Bằng: Zita-Rose Manjaly Thomas, et al.
Được phát hành: (2019-04-01)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
Bằng: Anne Wajja, et al.
Được phát hành: (2017-05-01)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
Bằng: Wajja, A, et al.
Được phát hành: (2017)

Phase I/II clinical trial of MVA85A in individuals with latent tuberculosis: The first subunit TB vaccine in clinical trial
Bằng: Sander, C, et al.
Được phát hành: (2005)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
Bằng: Minassian, A, et al.
Được phát hành: (2011)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
Bằng: Harris, S, et al.
Được phát hành: (2013)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
Bằng: Odutola, A, et al.
Được phát hành: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
Bằng: Odutola, A, et al.
Được phát hành: (2012)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naive subjects gives comparable immunogenicity to one dose in ART+ subjects
Bằng: Dieye, T, et al.
Được phát hành: (2013)

A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults
Bằng: Wilkie, M, et al.
Được phát hành: (2019)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
Bằng: Whelan, K, et al.
Được phát hành: (2009)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
Bằng: Pathan, A, et al.
Được phát hành: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
Bằng: Pathan, A, et al.
Được phát hành: (2012)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
Bằng: Owiafe, P, et al.
Được phát hành: (2012)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.
Bằng: Tandakha N Dieye, et al.
Được phát hành: (2013-01-01)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
Bằng: Kathryn T. Whelan, et al.
Được phát hành: (2011-01-01)

TB vaccine development: where are we and why is it so difficult?
Bằng: Wilkie, M, et al.
Được phát hành: (2014)

Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects.
Bằng: Tandakha N. Dieye, et al.
Được phát hành: (2013-01-01)

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
Bằng: Minhinnick, A, et al.
Được phát hành: (2016)

Diagnosis of extrapulmonary TB: Experience with the Xpert MTB/Rif assay
Bằng: C.N. Govind, et al.
Được phát hành: (2014-04-01)

Evaluation of Xpert MTB/RIF assay for the diagnosis of paediatric TB
Bằng: F. Ismail, et al.
Được phát hành: (2014-04-01)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
Được phát hành: (2011-01-01)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
Bằng: Raksha Rimal, et al.
Được phát hành: (2022-04-01)

Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil.
Bằng: Giovana Rodrigues Pereira, et al.
Được phát hành: (2018-01-01)

Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
Bằng: Neeraj Raizada, et al.
Được phát hành: (2014-01-01)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
Bằng: Mcshane, H, et al.
Được phát hành: (2016)

TB or not TB?
Bằng: Andrew Pirotte, et al.
Được phát hành: (2024-04-01)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
Bằng: Satti, I, et al.
Được phát hành: (2014)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial
Bằng: Satti, I, et al.
Được phát hành: (2014)